Genzyme’s predictions on the penalties levied for the ongoing problems at its manufacturing facility in Allston Landing have been confirmed, …
US biotech Genzyme is celebrating FDA approval of its late-onset treatment for Pompe disease Lumizyme. The green light to market …

The FDA seems to have lost patience with biotechnology company Genzyme over contamination problems at its manufacturing facilities, levying a …
Genzyme has appointed the head of one of its biggest shareholders to its board in order to block a hostile …
Manufacturing compliance problems continue to weigh down US biotechnology company Genzyme, with the US Food and Drug Administration now saying …

The contamination problems plaguing Genzyme in the US have also appeared in product manufactured at its plant in Waterford, Ireland, …

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …
Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …
Our round-up of developments in pharmaceutical manufacturing includes a new contract between Patheon and Sanofi-Aventis, hiring plans at Genzyme and …
Genzyme has appointed industry veteran Ron Branning as its new senior vice president of global product quality. Branning has 30 …
This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …
Genzyme has taken the decision to move the fill and finish stages of its manufacturing process to Hospira in order …

Another manufacturing contamination issue has beset Genzyme, just as it seemed to be overcoming the problems at its Allston Landing …

The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …